Poland· PL-100446997
Neurovit
A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum, registered in Poland by PharmaVitae Sp. z o.o. sp. k.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum is registered in 7 of 19 countries.
Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum · ATC A11DB
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum
- Manufacturer
- PharmaVitae Sp. z o.o. sp. k.
- Country
- Poland (PL)
- ATC code
- A11DB
- ATC class
- Vitamin B1 in combination with vitamin B6 and/or vitamin B12
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991447403
- gtin05909991447410
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEUROMAX FORTEVitabalans OY, Hämeenlinna
- SwitzerlandBenexol B12, FilmtablettenBayer (Schweiz) AG
- SpainANTINEURINA AMPOLLASMabo Farma S.A.
- FinlandNeurobion NMerck KGaA
- GermanyMilgamma NWörwag Pharma Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Citoneurin, Neurobion
- Belgium · Neurobion
- Bulgaria · Бевит Форте
- Cyprus · Betrimine
- Czechia · Neuromax Forte, Neuromultivit
- Germany · Milgamma N, Neurobion Zur Anwendung Bei Erwachsenen
- Estonia · Neuromax Forte, Neuromultivit
- Spain · Benexol, Hidroxil
- Finland · Neuromax Forte
- Greece · 3be, Be Union
- Hungary · Milgamma N, Neurogerlon
- Italy · Benexol
- Lithuania · Anoveb, Milgamma N
- Latvia · Milgamma N Injekt, Neuromax Forte
- Malta · Neuromultivit
- Portugal · Becorion, Associação, Neurobion, Associação
- Romania · Neuromultivit
- Slovakia · Neuromultivit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcdcf13a-0de0-43df-a33a-a254f25fd37f GET /v1/drugs/bcdcf13a-0de0-43df-a33a-a254f25fd37f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg + 200 mg + 0,20 mg",
"packaging": "05909991447403 ¦ Rp ¦ 139126\n20 tabl.\n05909991447410 ¦ Rp ¦ 139127\n100 tabl.",
"substance": "Thiamini hydrochloridum 100 mg + Pyridoxini hydrochloridum 200 mg + Cyanocobalaminum 0.2 mg",
"common_name": "Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum",
"pl_product_id": "100446997",
"pozwolenie_nr": "43/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-02-04"
}See everything about thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.